These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38355238)

  • 1. Renal manifestations in adults with mitochondrial disease from the mtDNA m.3243A>G pathogenic variant.
    Ferreira F; Gonçalves Bacelar C; Lisboa-Gonçalves P; Paulo N; Quental R; Nunes AT; Silva R; Tavares I
    Nefrologia (Engl Ed); 2023 Dec; 43 Suppl 2():1-7. PubMed ID: 38355238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One mutation, three phenotypes: novel metabolic insights on MELAS, MIDD and myopathy caused by the m.3243A > G mutation.
    Esterhuizen K; Lindeque JZ; Mason S; van der Westhuizen FH; Rodenburg RJ; de Laat P; Smeitink JAM; Janssen MCH; Louw R
    Metabolomics; 2021 Jan; 17(1):10. PubMed ID: 33438095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A>G mutation--implications for diagnosis and management.
    Nesbitt V; Pitceathly RD; Turnbull DM; Taylor RW; Sweeney MG; Mudanohwo EE; Rahman S; Hanna MG; McFarland R
    J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):936-8. PubMed ID: 23355809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic derangement in amino acid profile during and after a stroke-like episode in adult-onset mitochondrial disease: a case report.
    Fukuda M; Nagao Y
    J Med Case Rep; 2019 Oct; 13(1):313. PubMed ID: 31630688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIDD or MELAS : that's not the question MIDD evolving into MELAS : a severe phenotype of the m.3243A>G mutation due to paternal co-inheritance of type 2 diabetes and a high heteroplasmy level.
    de Wit HM; Westeneng HJ; van Engelen BG; Mudde AH
    Neth J Med; 2012 Dec; 70(10):460-2. PubMed ID: 23230016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The heart in m.3243A>G carriers.
    Finsterer J; Zarrouk-Mahjoub S
    Herz; 2020 Jun; 45(4):356-361. PubMed ID: 30128910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation in mitochondrial DNA in a patient with diabetes, deafness and proteinuria.
    Adema AY; Janssen MC; van der Heijden JW
    Neth J Med; 2016 Dec; 74(10):455-457. PubMed ID: 27966441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five non-mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes phenotype adult patients with m.3243A>G mutation after kidney transplantation: follow-up and review of the literature.
    de Laat P; van Engelen N; Wetzels JF; Smeitink JAM; Janssen MCH
    Clin Kidney J; 2019 Dec; 12(6):840-846. PubMed ID: 31807297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial DNA mutation "m.3243A>G"-Heterogeneous clinical picture for cardiologists ("m.3243A>G": A phenotypic chameleon).
    Niedermayr K; Pölzl G; Scholl-Bürgi S; Fauth C; Schweigmann U; Haberlandt E; Albrecht U; Zlamy M; Sperl W; Mayr JA; Karall D
    Congenit Heart Dis; 2018 Sep; 13(5):671-677. PubMed ID: 30133155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case with short stature and proteinuria: atypical presentation of a family with m.3243A>G mutation.
    Büyükyılmaz G; İnözü M; Çavdarlı B
    Turk J Pediatr; 2024 Oct; 66(4):490-498. PubMed ID: 39387423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of nuclear and mitochondrial gene mutations in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome.
    Chakrabarty S; Govindaraj P; Sankaran BP; Nagappa M; Kabekkodu SP; Jayaram P; Mallya S; Deepha S; Ponmalar JNJ; Arivinda HR; Meena AK; Jha RK; Sinha S; Gayathri N; Taly AB; Thangaraj K; Satyamoorthy K
    J Neurol; 2021 Jun; 268(6):2192-2207. PubMed ID: 33484326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal involvement in MELAS syndrome - a series of 5 cases and review of the literature.
    Seidowsky A; Hoffmann M; Glowacki F; Dhaenens CM; Devaux JP; de Sainte Foy CL; Provot F; Gheerbrant JD; Hummel A; Hazzan M; Dracon M; Dieux-Coeslier A; Copin MC; Noël C; Buob D
    Clin Nephrol; 2013 Dec; 80(6):456-63. PubMed ID: 22909780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive quantification of m.3243A>G mutational proportion in non-retinal tissues and its relationship with visual symptoms.
    Mullin NK; Anfinson KR; Riker MJ; Wieland KL; Tatro NJ; Scheetz TE; Mullins RF; Stone EM; Tucker BA
    Hum Mol Genet; 2022 Mar; 31(5):775-782. PubMed ID: 34590675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multisystem Mitochondrial Disease Caused by a Novel MT-TL1 mtDNA Variant: A Case Report.
    Giannese D; Montano V; Lopriore P; Nesti C; LoGerfo A; Caligo MA; Dal Canto F; Pasquinelli G; Bonadio AG; Moriconi D; Siciliano G; Mancuso M
    J Neuromuscul Dis; 2023; 10(1):119-123. PubMed ID: 36404555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anatomic & metabolic brain markers of the m.3243A>G mutation: A multi-parametric 7T MRI study.
    Haast RAM; Ivanov D; IJsselstein RJT; Sallevelt SCEH; Jansen JFA; Smeets HJM; de Coo IFM; Formisano E; Uludağ K
    Neuroimage Clin; 2018; 18():231-244. PubMed ID: 29868447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The m.3243A>G mitochondrial DNA mutation and related phenotypes. A matter of gender?
    Mancuso M; Orsucci D; Angelini C; Bertini E; Carelli V; Comi GP; Donati A; Minetti C; Moggio M; Mongini T; Servidei S; Tonin P; Toscano A; Uziel G; Bruno C; Ienco EC; Filosto M; Lamperti C; Catteruccia M; Moroni I; Musumeci O; Pegoraro E; Ronchi D; Santorelli FM; Sauchelli D; Scarpelli M; Sciacco M; Valentino ML; Vercelli L; Zeviani M; Siciliano G
    J Neurol; 2014 Mar; 261(3):504-10. PubMed ID: 24375076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forecasting stroke-like episodes and outcomes in mitochondrial disease.
    Ng YS; Lax NZ; Blain AP; Erskine D; Baker MR; Polvikoski T; Thomas RH; Morris CM; Lai M; Whittaker RG; Gebbels A; Winder A; Hall J; Feeney C; Farrugia ME; Hirst C; Roberts M; Lawthom C; Chrysostomou A; Murphy K; Baird T; Maddison P; Duncan C; Poulton J; Nesbitt V; Hanna MG; Pitceathly RDS; Taylor RW; Blakely EL; Schaefer AM; Turnbull DM; McFarland R; Gorman GS
    Brain; 2022 Apr; 145(2):542-554. PubMed ID: 34927673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. THE ROLE OF HETEROPLASMY IN THE DIAGNOSIS AND MANAGEMENT OF MATERNALLY INHERITED DIABETES AND DEAFNESS.
    Robinson KN; Terrazas S; Giordano-Mooga S; Xavier NA
    Endocr Pract; 2020 Feb; 26(2):241-246. PubMed ID: 31682520
    [No Abstract]   [Full Text] [Related]  

  • 19. De Novo Mutation of m.3243A>G together with m.16093T>C Associated with Atypical Clinical Features in a Pedigree with MIDD Syndrome.
    Jiang Z; Zhang Y; Yan J; Li F; Geng X; Lu H; Wei X; Feng Y; Wang C; Jia W
    J Diabetes Res; 2019; 2019():5184647. PubMed ID: 31143779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal imaging analysis of macular dystrophy in patient with maternally inherited diabetes and deafness (MIDD) with m.3243A>G mutation.
    Oishi N; Kubota D; Nakamoto K; Takeda Y; Hayashi M; Gocho K; Yamaki K; Igarashi T; Takahashi H; Kameya S
    Ophthalmic Genet; 2021 Jun; 42(3):304-311. PubMed ID: 33541179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.